Gary L Crocker, Founder & Managing Director & President at Crocker Ventures, Cottonwood Heights. See sector focus and contact routes.
Gary L. Crocker is the President, Managing Director, and founder of Crocker Ventures, an independent, privately held life science and healthcare investment firm he established in 2004 after founding Research Medical in 1983 and selling it for $236 million. The firm targets seed- and early-stage companies primarily in life science, healthcare, biotechnology, pharmaceuticals, medical devices, and high technology, with a focus on intellectual property and innovative technological solutions. Crocker Ventures typically makes investments ranging up to at least $6.0 million, as seen in its June 2025 Series A lead investment in Rebel Medicine, and generally acts as a lead investor in early deals. Notable portfolio companies include Rebel Medicine, TellBio (Series A in October 2024), and Merrimack Pharmaceuticals, a personalized oncology firm where Crocker serves as Chairman and has held the role since 2004. Crocker also chairs three orthopedic medical device firms—Nexus CMF, Nexus Spine, and Nexus TDR—reflecting his hands-on approach to medical device innovation. He has been twice named Utah Entrepreneur of the Year and inducted into the University of
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Cottonwood Heights.
Investors like Gary L Crocker · Full investor directory · Investor access · Company funding database